Putnam Investments LLC Ngm Biopharmaceuticals Inc Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$3.72 - $5.4 $54,721 - $79,434	14,710 Added 48.81%	44,848 $182,000
Q4 2022 Feb 14, 2023	SELL	$3.41 - $12.93 $23,058 - $87,432	-6,762 Reduced 18.33%	30,138 $151,000
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $8,384 - $11,768	-666 Reduced 1.77%	36,900 $483,000
Q2 2022 Aug 15, 2022	SELL	$10.58 - $17.5 $4,718 - $7,805	-446 Reduced 1.17%	37,566 $482,000
Q1 2022 May 16, 2022	BUY	$13.81 - $18.6 $136,995 - $184,512	9,920 Added 35.31%	38,012 $580,000
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $484,867 - $618,585	28,092 New	28,092 $497,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.